Peripheral NLR family pyrin domain-containing 3 protein pathway participates in the development of orofacial inflammatory pain in rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The study aimed to investigate the role of peripheral NLR family pyrin domain-containing 3 protein (NLRP3) in inflammatory pain development in the orofacial area. Male Sprague–Dawley rats were used in experiments, with orofacial formalin-induced pain behavior and complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia as chronic inflammatory pain models. Administration of 5% formalin produced biphasic nociceptive behavior, and subcutaneous pretreatment with MCC950 (50 and 100 μg/50 μL), an NLRP3 inhibitor, remarkably attenuated nociceptive behavior during the second phase. Subcutaneous CFA injection induced thermal hyperalgesia 1 day after injection, which persisted for 7 days. Five days after CFA injection, subcutaneous treatment with MCC950 (50 and 100 μg/50 μL) significantly attenuated thermal hyperalgesia. Additionally, subcutaneous injection of BMS-986299 (50 and 100 μg/50 μL), an NLRP3 agonist, induced significant nociceptive behavior for 1 hour in naïve rats. Pretreatment with an interleukin- 1β (IL-1β) receptor antagonist blocked the nociceptive behavior produced by subcutaneous injection of BMS-986299 (100 μg/50 μL); however, treatment with a hypoxia-inducible factor 1α inhibitor did not. These findings suggest the involvement of the peripheral NLRP3 and IL-1β pathway in chronic inflammatory pain development in the orofacial area, highlighting the potential of blocking this pathway as a strategy for developing future inflammatory pain treatment drugs.
Abstract
The study aimed to investigate the role of peripheral NLR family pyrin domain-containing 3 protein (NLRP3) in inflammatory pain development in the orofacial area. Male Sprague–Dawley rats were used in experiments, with orofacial formalin-induced pain behavior and complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia as chronic inflammatory pain models. Administration of 5% formalin produced biphasic nociceptive behavior, and subcutaneous pretreatment with MCC950 (50 and 100 μg/50 μL), an NLRP3 inhibitor, remarkably attenuated nociceptive behavior during the second phase. Subcutaneous CFA injection induced thermal hyperalgesia 1 day after injection, which persisted for 7 days. Five days after CFA injection, subcutaneous treatment with MCC950 (50 and 100 μg/50 μL) significantly attenuated thermal hyperalgesia. Additionally, subcutaneous injection of BMS-986299 (50 and 100 μg/50 μL), an NLRP3 agonist, induced significant nociceptive behavior for 1 hour in naïve rats. Pretreatment with an interleukin- 1β (IL-1β) receptor antagonist blocked the nociceptive behavior produced by subcutaneous injection of BMS-986299 (100 μg/50 μL); however, treatment with a hypoxia-inducible factor 1α inhibitor did not. These findings suggest the involvement of the peripheral NLRP3 and IL-1β pathway in chronic inflammatory pain development in the orofacial area, highlighting the potential of blocking this pathway as a strategy for developing future inflammatory pain treatment drugs.
참고문헌 (28)
- Schroder K, "The inf lammasomes", Cell, 140, pp.821~832 (2010)[DOI]
- Strowig T, "Inflammasomes in health and disease", Nature, 481, pp.278~286 (2012)[DOI]
- de Zoete MR, "Interactions between nod-like receptors and intestinal bacteria", Front Immunol, 4, pp.462~ (2013)[DOI]
- Latz E, "Activation and regulation of the inflammasomes", Nat Rev Immunol, 13, pp.397~411 (2013)[DOI]
- Ratsimandresy RA, "An update on PYRIN domain-containing pattern recognition receptors : from immunity to pathology", Front Immunol, 4, pp.440~ (2013)[DOI]
- He Y, "Mechanism and regulation of NLRP3 inflammasome activation", Trends Biochem Sci, 41, pp.1012~1021 (2016)[DOI]
- Yu S, "Muscone relieves inflammatory pain by inhibiting microglial activation-mediated inflammatory response via abrogation of the NOX4", JAK2-STAT3 pathway and NLRP3 inflammasome, 2020, pp.82, 106355~
- Xu L, "MiR-34c ameliorates neuropathic pain by targeting NLRP3 in a mouse model of chronic constriction injury", Neuroscience, 399, pp.125~134 (2019)[DOI]
- Sun S, "Ligand-gated ion channel P2X7 regulates NLRP3", Caspase-1-mediated inflammatory pain caused by pulpitis in the trigeminal ganglion and medullary dorsal horn, 2023, pp.192, 1~10
- Lee HJ, "Intracisternal NMDA produces analgesia in the orofacial formalin test of freely moving rats", Prog Neuropsychopharmacol Biol Psychiatry, 28, pp.497~503 (2004)[DOI]
- Ahn DK, "Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats", Pain, 117, pp.204~213 (2005)[DOI]
- Choi HS, "Central cyclooxygenase-2 participates in interleukin-1 betainduced hyperalgesia in the orofacial formalin test of freely moving rats", Neurosci Lett, 352, pp.187~190 (2003)[DOI]
- Lee G, "Blockade of central vascular endothelial growth factor-A pathway attenuates inf lammatory orofacial pain in rats", Oral Biol Res, 47, pp.151~158 (2023)[DOI]
- Kim HJ, "Antinociceptive effects of transcytosed botulinum neurotoxin type A on trigeminal nociception in rats", Korean J Physiol Pharmacol, 19, pp.349~355 (2015)[DOI]
- Han SR, "Early dexamethasone relieves trigeminal neuropathic pain", J Dent Res, 89, pp.915~920 (2010)[DOI]
- Park CK, "Molecular mechanism for local anesthetic action of eugenol in the rat trigeminal system", Pain, 144, pp.84~94 (2009)[DOI]
- Tan S, "The molecular mechanisms associated with the effects of propofol in a rat model of pain due to inflammation following injection with complete Freundʼs adjuvant", Med Sci Monit, 25, pp.10190~10197 (2019)[DOI]
- Silva Santos Ribeiro P, "NLRP3 inflammasome activation in sensory neurons promotes chronic inflammatory and osteoarthritis pain", Immunother Adv, 3, pp.ltad022~ (2023)[DOI]
- Lin J, "Dimethyl itaconate attenuates CFA-induced inf lammatory pain via the NLRP3", IL-1β signaling pathway, 2022, pp.13, 938979~
- Pan Z, "miRNA-23a", CXCR4 regulates neuropathic pain via directly targeting TXNIP, J Neuroinflammation, pp.2018, 15[DOI]
- Gao F, "Electroacupuncture inhibits NLRP3 inf lammasome activation through CB2 receptors in inflammatory pain", Brain Behav Immun, 67, pp.91~100 (2018)[DOI]
- Kodji X, "Evidence that a TRPA1-mediated murine model of temporomandibular joint pain involves NLRP3inflammasome activation", Pharmaceuticals(Basel), 14, pp.1073~ (2021)[DOI]
- Arman A, "In vivo intrathecal IL-1β quantification in rats : monitoring the molecular signals of neuropathic pain", Brain Behav Immun, 88, pp.442~450 (2020)[DOI]
- Liu ZY, "CXCL12", CXCR4 signaling contributes to neuropathic pain via central sensitization mechanisms in a rat spinal nerve ligation model, 2019, pp.25, 922~936
- Wang YH, "The anti-inflammatory and analgesic effects of intraperitoneal melatonin after spinal nerve ligation are mediated by inhibition of the NF-κB", NLRP3 inflammasome signaling pathway, 2021, pp.169, 156~166
- Charpentier T, "Hypoxia inducible factor 1α : a critical factor for the immune response to pathogens and Leishmania", Cell Immunol, 309, pp.42~49 (2016)[DOI]
- Cho JH, "Cellular mechanisms mediating the antinociceptive effect of botulinum toxin A in a rodent model of trigeminal irritation by a foreign body", J Pain, 23, pp.2070~2079 (2022)[DOI]
- Green-Fulgham SM, "Interleukin-1beta and inflammasome expression in spinal cord following chronic constriction injury in male and female rats", Brain Behav Immun, 115, pp.157~168 (2024)[DOI]